Evidence map›Paper›PMID 29038446›Full record

ArticleScientific reports2017

External Quality Assurance for Laboratory Identification and Capsular Typing of Streptococcus pneumoniae.

Hans-Christian Slotved, Carmen L Sheppard, Tine Dalby, Arie van der Ende, Norman K Fry, Eva Morfeldt, Outi Nyholm, Assaf Rokney, Merav Ron, Lotta Siira and 5 more

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Hans-Christian SlotvedDepartment of Bacteria, Parasites and Fungi - Neisseria and Streptococcus Reference Laboratory, Statens Serum Institut, Copenhagen, Denmark. hcs@ssi.dk.ORCID 0000-0002-7294-4911
Carmen L SheppardRespiratory and Vaccine Preventable Bacteria Reference Unit, Public Health England-National Infection Service, London, UK.
Tine DalbyDepartment of Bacteria, Parasites and Fungi - Neisseria and Streptococcus Reference Laboratory, Statens Serum Institut, Copenhagen, Denmark.
Arie van der EndeDepartment of Medical Microbiology and the Netherlands Reference Laboratory for Bacterial Meningitis, Academic Medical Center, Amsterdam, The Netherlands.
Norman K FryRespiratory and Vaccine Preventable Bacteria Reference Unit, Public Health England-National Infection Service, London, UK.ORCID 0000-0003-4862-6507
Eva MorfeldtDepartment of Microbiology, Laboratory Surveillance of Bacterial Pathogens, The Public Health Agency of Sweden, Solna, Sweden.
Outi NyholmDepartment of Health Security, National Institute for Health and Welfare, Helsinki, Finland.
Assaf RokneyGovernment Central Laboratories, Ministry of Health, Jerusalem, Israel.
Merav RonGovernment Central Laboratories, Ministry of Health, Jerusalem, Israel.
Lotta SiiraDepartment of Health Security, National Institute for Health and Welfare, Helsinki, Finland.
Kevin J ScottScottish Haemophilus Legionella Meningococcus & Pneumococcus Reference Laboratory (SHLMPRL), New Lister Building, Glasgow Royal Infirmary, Glasgow, Scotland, UK.
Andrew SmithScottish Haemophilus Legionella Meningococcus & Pneumococcus Reference Laboratory (SHLMPRL), New Lister Building, Glasgow Royal Infirmary, Glasgow, Scotland, UK.
Louise ThomScottish Haemophilus Legionella Meningococcus & Pneumococcus Reference Laboratory (SHLMPRL), New Lister Building, Glasgow Royal Infirmary, Glasgow, Scotland, UK.
Maija ToropainenDepartment of Health Security, National Institute for Health and Welfare, Helsinki, Finland.
Didrik F VestrheimDepartment of vaccine preventable diseases, Norwegian Institute of Public Health, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An external quality assessment (EQA) scheme for pneumococcal serotype identification has been performed over a period of 11 years, by a network of European pneumococcal reference laboratories. We report the results from the EQA, and present an assessment of the acceptability and utility of the EQA scheme. Reports from 22 EQA panels distributed in 2005-2016 were analysed. Each EQA panel consisted of seven isolates. A questionnaire including seven questions related to the acceptability and utility of the EQA scheme was distributed to all participating laboratories. Altogether, 154 pneumococcal isolates were tested. Of the 92 serologically distinct serotypes currently defined, 49 serotypes were included in the rounds. Discrepant results were observed in eight EQA rounds, involving 11 isolates (7.1%, 95% CI: 4% to 12%). All participating laboratories reported that the EQA scheme was useful for quality assurance purposes. Our results show that comparable serotyping data can be obtained in different laboratories. The EQA participation helps to keep the typing procedures at a high standard and provides data for accreditation purposes. The EQA is helpful when new technologies are introduced, and reveal limitations of both genotypic and phenotypic methods. Continuation of the presented EQA scheme is planned.

Indexed as

Quality Assurance, Health CareBacterial Typing TechniquesEuropeGenotypeHumansReproducibility of ResultsSerogroupSerotypingStreptococcus pneumoniae

Identifiers

PMID29038446
PMCPMC5643306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.